Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review

BACKGROUND: Deprescribing, defined as discontinuing or reducing the dose of medications that are no longer needed or for which the risks outweigh the benefits is a way to reduce polypharmacy. In 2022, the US Deprescribing Research Network (USDeN) published recommendations concerning the measurement...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizet, Pierre, Evin, Adrien, Brociero, Emma, Vigneau, Caroline Victorri, Huon, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337166/
https://www.ncbi.nlm.nih.gov/pubmed/37438697
http://dx.doi.org/10.1186/s12877-023-04155-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337166/
https://www.ncbi.nlm.nih.gov/pubmed/37438697
http://dx.doi.org/10.1186/s12877-023-04155-y

Ejemplares similares